Update: 25.03.2025
Last week: 11 week 2024 (10.03.2025 - 16.03.2025)
Last full month: February 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 11 205 | 16.0% | 13.1% | 0.1 | 24 394 962 | 16.6% | 9.7% | 0.1 | 14.7% |
| MoM | 37 047 | 9.5% | 12.5% | -0.4 | 80 317 567 | 15.8% | 9.4% | 0 | 13.1% |
| YTD | 96 211 | 28.8% | 12.8% | 1.8 | 204 206 265 | 21.7% | 9.4% | -0.1 | 11.1% |
| MAT | 442 963 | 24.1% | 12.7% | 3.1 | 875 527 760 | 21.6% | 9.3% | 1.1 | -6.1% |
| BRAINMAX | |||||||||
| WoW | 3 117 | 1.0% | 100.0% | 0 | 10 502 820 | 3.7% | 100.0% | 0 | 1.0% |
| MoM | 9 443 | 11.3% | 100.0% | 0 | 32 675 026 | 8.0% | 100.0% | 0 | 11.3% |
| YTD | 25 359 | 138.0% | 100.0% | 0 | 87 700 671 | 128.6% | 100.0% | 0 | 138.0% |
| MAT | 97 369 | 91.0% | 100.0% | 0 | 336 062 575 | 88.7% | 100.0% | 0 | 91.0% |
| GOLDLINE PLUS | |||||||||
| WoW | 18 681 | 10.3% | 46.9% | -0.4 | 60 148 527 | 10.4% | 38.5% | 0 | 11.2% |
| MoM | 65 902 | 0.9% | 45.0% | -0.4 | 214 432 366 | 1.4% | 36.5% | -1.2 | 1.8% |
| YTD | 174 583 | -2.4% | 45.6% | 1.7 | 565 611 462 | -1.8% | 37.3% | 1.2 | -6.0% |
| MAT | 824 802 | -6.0% | 45.8% | 0.5 | 2 592 707 307 | -5.8% | 37.4% | -1.8 | -6.9% |
| MIGRENIUM | |||||||||
| WoW | 9 010 | -0.4% | 0.3% | 0 | 3 178 490 | 0.2% | 0.5% | 0 | 4.2% |
| MoM | 35 529 | 7.2% | 0.4% | 0 | 12 281 102 | 6.2% | 0.5% | 0 | 0.2% |
| YTD | 91 211 | -31.2% | 0.4% | -0.2 | 31 769 126 | -14.5% | 0.5% | -0.1 | 3.5% |
| MAT | 526 471 | -17.8% | 0.4% | -0.1 | 176 284 340 | 29.8% | 0.6% | 0.1 | 0.4% |
| MODELAX-N | |||||||||
| WoW | 29 365 | 1.8% | 19.2% | 0 | 15 301 587 | 0.8% | 13.7% | -0.1 | 1.9% |
| MoM | 138 451 | 5.0% | 22.4% | 1.3 | 71 486 517 | 5.4% | 15.9% | 1.1 | -0.9% |
| YTD | 345 087 | 1.6% | 21.2% | -1.6 | 178 329 102 | 29.2% | 15.0% | 1 | 9.3% |
| MAT | 1 469 132 | 13.1% | 21.4% | 1.5 | 699 614 695 | 54.1% | 14.4% | 3.1 | 5.0% |
| REDUXIN | |||||||||
| WoW | 12 667 | 11.7% | 31.8% | 0.1 | 67 846 159 | 9.5% | 43.4% | -0.3 | 11.2% |
| MoM | 47 539 | 4.1% | 32.5% | 0.7 | 264 568 793 | 8.3% | 45.0% | 1.5 | 1.8% |
| YTD | 122 764 | -9.7% | 32.0% | -1.3 | 668 961 670 | -9.2% | 44.1% | -2.1 | -6.0% |
| MAT | 582 226 | -7.5% | 32.3% | -0.2 | 3 095 387 578 | 2.6% | 44.7% | 1.7 | -6.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 743 | 6.3% | 9.4% | -0.4 | 17 243 784 | 10.1% | 11.0% | 0 | 11.2% |
| MoM | 15 088 | 7.4% | 10.3% | 0.5 | 67 355 303 | 6.8% | 11.5% | 0.2 | 1.8% |
| YTD | 38 227 | 6.6% | 10.0% | 1.2 | 171 636 898 | 8.2% | 11.3% | 1.4 | -6.0% |
| MAT | 169 712 | 0.1% | 9.4% | 0.7 | 734 660 160 | 6.0% | 10.6% | 0.7 | -6.9% |
| SALVISAR | |||||||||
| WoW | 13 241 | 3.8% | 1.7% | -0.1 | 6 592 667 | 4.4% | 1.7% | 0 | 7.2% |
| MoM | 64 379 | 17.6% | 2.2% | 0.4 | 30 950 520 | 19.7% | 2.0% | 0.4 | -2.1% |
| YTD | 152 584 | 58.0% | 1.9% | 0.8 | 73 239 785 | 104.7% | 1.8% | 0.8 | -3.4% |
| MAT | 627 805 | 32.3% | 1.6% | 0.5 | 278 404 651 | 73.2% | 1.5% | 0.5 | -6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 96 211 | 28.8% | 12.8% | 1.8 | 204 206 265 | 21.7% | 9.4% | -0.1 | 11.1% |
| BRAINMAX | 25 359 | 138.0% | 100.0% | 0 | 87 700 671 | 128.6% | 100.0% | 0 | 138.0% |
| GOLDLINE PLUS | 174 583 | -2.4% | 45.6% | 1.7 | 565 611 462 | -1.8% | 37.3% | 1.2 | -6.0% |
| MIGRENIUM | 91 211 | -31.2% | 0.4% | -0.2 | 31 769 126 | -14.5% | 0.5% | -0.1 | 3.5% |
| MODELAX-N | 345 087 | 1.6% | 21.2% | -1.6 | 178 329 102 | 29.2% | 15.0% | 1 | 9.3% |
| REDUXIN CAPS | 122 764 | -9.7% | 32.0% | -1.3 | 668 961 670 | -9.2% | 44.1% | -2.1 | -6.0% |
| REDUXIN FORTE | 38 227 | 6.6% | 10.0% | 1.2 | 171 636 898 | 8.2% | 11.3% | 1.4 | -6.0% |
| SALVISAR | 152 584 | 58.0% | 1.9% | 0.8 | 73 239 785 | 104.7% | 1.8% | 0.8 | -3.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 442 963 | 24.1% | 12.7% | 3.1 | 875 527 760 | 21.6% | 9.3% | 1.1 | -6.1% |
| BRAINMAX | 97 369 | 91.0% | 100.0% | 0 | 336 062 575 | 88.7% | 100.0% | 0 | 91.0% |
| GOLDLINE PLUS | 824 802 | -6.0% | 45.8% | 0.5 | 2 592 707 307 | -5.8% | 37.4% | -1.8 | -6.9% |
| MIGRENIUM | 526 471 | -17.8% | 0.4% | -0.1 | 176 284 340 | 29.8% | 0.6% | 0.1 | 0.4% |
| MODELAX-N | 1 469 132 | 13.1% | 21.4% | 1.5 | 699 614 695 | 54.1% | 14.4% | 3.1 | 5.0% |
| REDUXIN CAPS | 582 226 | -7.5% | 32.3% | -0.2 | 3 095 387 578 | 2.6% | 44.7% | 1.7 | -6.9% |
| REDUXIN FORTE | 169 712 | 0.1% | 9.4% | 0.7 | 734 660 160 | 6.0% | 10.6% | 0.7 | -6.9% |
| SALVISAR | 627 805 | 32.3% | 1.6% | 0.5 | 278 404 651 | 73.2% | 1.5% | 0.5 | -6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 11 205 | 16.0% | 13.1% | 0.1 | 24 394 962 | 16.6% | 9.7% | 0.1 | 14.7% |
| BRAINMAX | 3 117 | 1.0% | 100.0% | 0 | 10 502 820 | 3.7% | 100.0% | 0 | 1.0% |
| GOLDLINE PLUS | 18 681 | 10.3% | 46.9% | -0.4 | 60 148 527 | 10.4% | 38.5% | 0 | 11.2% |
| MIGRENIUM | 9 010 | -0.4% | 0.3% | 0 | 3 178 490 | 0.2% | 0.5% | 0 | 4.2% |
| MODELAX-N | 29 365 | 1.8% | 19.2% | 0 | 15 301 587 | 0.8% | 13.7% | -0.1 | 1.9% |
| REDUXIN CAPS | 12 667 | 11.7% | 31.8% | 0.1 | 67 846 159 | 9.5% | 43.4% | -0.3 | 11.2% |
| REDUXIN FORTE | 3 743 | 6.3% | 9.4% | -0.4 | 17 243 784 | 10.1% | 11.0% | 0 | 11.2% |
| SALVISAR | 13 241 | 3.8% | 1.7% | -0.1 | 6 592 667 | 4.4% | 1.7% | 0 | 7.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 37 047 | 9.5% | 12.5% | -0.4 | 80 317 567 | 15.8% | 9.4% | 0 | 13.1% |
| BRAINMAX | 9 443 | 11.3% | 100.0% | 0 | 32 675 026 | 8.0% | 100.0% | 0 | 11.3% |
| GOLDLINE PLUS | 65 902 | 0.9% | 45.0% | -0.4 | 214 432 366 | 1.4% | 36.5% | -1.2 | 1.8% |
| MIGRENIUM | 35 529 | 7.2% | 0.4% | 0 | 12 281 102 | 6.2% | 0.5% | 0 | 0.2% |
| MODELAX-N | 138 451 | 5.0% | 22.4% | 1.3 | 71 486 517 | 5.4% | 15.9% | 1.1 | -0.9% |
| REDUXIN CAPS | 47 539 | 4.1% | 32.5% | 0.7 | 264 568 793 | 8.3% | 45.0% | 1.5 | 1.8% |
| REDUXIN FORTE | 15 088 | 7.4% | 10.3% | 0.5 | 67 355 303 | 6.8% | 11.5% | 0.2 | 1.8% |
| SALVISAR | 64 379 | 17.6% | 2.2% | 0.4 | 30 950 520 | 19.7% | 2.0% | 0.4 | -2.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs